Mafalda Laranjo

Institute of Biophysics, Faculty of Medicine

University of Coimbra

Mafalda Laranjo

Mafalda Laranjo obtained a degree in Biology in 2006, a master's degree in Cellular and Molecular Biology in 2010, and a Ph.D. degree in 2014 at the University of Coimbra. She is currently an Investigator at the Faculty of Medicine, University of Coimbra.

Dr. Laranjo's main scientific interest is Photodynamic therapy (PDT) applied to cancer treatment. In this field, she has developed and patented new compounds and has demonstrated its selective cytotoxicity in several cancer types, both in vitro and in vivo. Also, Dr. Laranjo has been working in multidisciplinary teams focusing on oncology, dentistry, gynecology, and ophthalmology research, contributing with her know-how on primary cell cultures, cellular and molecular technique's and animal models, like mouse and rat. At the same time, she contributes to science dissemination and network formation, being actively involved in international projects in South Europe regarding cancer research.

Dr. Laranjo develops her work at Coimbra Institute for Clinical and Biomedical Research (iCBR)/Centre for Innovative Biomedicine and Biotechnology (CIBB), where besides her research activities, she is enrolled in teaching activities of under and postgraduate studies and supervision of BSc, MSc, and Ph.D. students.

Publications

Sitotoksisiteye Erişim ve Biyomateryallere Hücre Yanıtı

*1,2,3,4, *2,3,4,5, 1,2,3,4, 2,3,4,5, 2,3,4,6, 2,3,4,6, 2,3,4,7, 2,3,4,5, 1,2,3,4,8, 1,2,3,4

1Institute of Integrated Clinical Practice, Faculty of Medicine, University of Coimbra, Coimbra, Portugal, 2Coimbra Institute for Clinical and Biomedical Research (iCBR) area of Environment Genetics and Oncobiology (CIMAGO), University of Coimbra, Coimbra, Portugal, 3Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal, 4Clinical Academic Center of Coimbra, CACC, Portugal, 5Institute of Biophysics, Faculty of Medicine, University of Coimbra, Coimbra, Portugal, 6Laboratory of Oncobiology and Hematology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal, 7Institute of Endodontics, Faculty of Medicine, University of Coimbra, Coimbra, Portugal, 8Institute of Experimental Pathology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal

JoVE 61512

 Medicine

Jinekolojik ve Meme Kanseri Tümörlerinden Kanser Kök Hücre Kürelerinin Alınması

*1,2,3,4, *1,2,3,4,5,6, 1,2,3, 2,7, 1,2,3,4,8, 9, 3,9,10, 1,2,3,4,8

1Institute of Biophysics, Faculty of Medicine, University of Coimbra, 2Coimbra Institute for Clinical and Biomedical Research (iCBR), area of Environment Genetics and Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, 3CNC.IBILI/Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 4Clinical Academic Center of Coimbra (CACC), 5Universitary Clinic of Gynecology, Faculty of Medicine, University of Coimbra, 6Gynecology A Service, Coimbra Hospital and Universitary Center, 7Institute of Pharmacology & Experimental Therapeutics, Faculty of Medicine, University of Coimbra, 8Institute of Experimental Pathology, Faculty of Medicine, University of Coimbra, 9Cytometry Operational Management Unit, Clinical Pathology Service, Coimbra Hospital and Universitary Center, 10Polytechnic Institute of Coimbra, ESTESC-Coimbra Health School, Laboratory Biomedical Sciences

JoVE 60022

 Cancer Research